4LAURIN J,LINDOR KD,CRIPPIN JS,et al.Ursodeoxycholic acid of clofibrate in the treatment of nonalcoholic-induced steato-hepatitis:a pilot study[J].Hepatology,1996,23:1464. 被引量：1
5BASARANOGLU M,ACBAY O,SONSUZ A.A controlled trial of gemfibrol in the treatment of patients with nonalcoholic steatohepatitis[J].J Hepatol,1999,31:384. 被引量：1
6HARANO Y,YASUI K,et al.Fenofibrate,a peroxisome proliferator-acti-vated receptor alpha agonist,reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver[J].Liver.Int,2006,26(5):613. 被引量：1
7MERAT S,MALEKZADEH R,SOHRABI MR,et al.Probucol in the treatment of nonalcoholic steatohepatitis:an open-labeled study[J].J Clin Gastroenterol,2003,17 (12):713. 被引量：1
8KIYICI M,GULTEN M,GUREL S,et al.Ursodeoxycholic acid and atorvastain in the treatment of nonalcoholic steatohepatitis[J].Can J Gastroenterol,2003,17 (12):713. 被引量：1
9GOMEZ-DOMINGUEZ E.A pilot study of atorvastatin treatment in dyslipemid,non-alcoholic fatty liver patients[J].Aliment Pharmacol Ther,2006,24(4):698. 被引量：1
10LOUKIANOS S.RALLIDIS,et al.Pravastatin in patients with nonalcoholic steatohepatitis:results of a pilot study[J].Atherosclerosis,2004(174):193. 被引量：1
4Levine L. Statins stimulate arachidonic acid release and prostaglandin 12 production in rat liver cells. Lipids Health Dis,2003,12 : 1-4. 被引量：1
5Rombouts K, Kisanga E, Hellemans K,et al. Effect of H MG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells. J Hepatol,2003 ,38 :564-572. 被引量：1
6Zafra C, Abraldes JG,Turnes J,et al. Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis. Gastroenterology ,2004,126:749-755. 被引量：1
